BRD0209 is a potent, selective and dual inhibitor of GSK3alpha/beta inhibitor (GSK3alpha IC50 = 19 nM, GSK3beta IC50 = 5 nM). BRD0209 is also a reversible ATP-competitive inhibitor with fast-off kinetics (Ki = 4.2 nM, respectively). BRD0209 is a tricyclic pyrazolotetrahydroquinolinone compound. BRD0209 has the potential for the research of mood disorder diseases[1].
Molekulargewicht:
347.45
Reinheit:
99.63
CAS Nummer:
[1597439-87-6]
Formel:
C22H25N3O
Target-Kategorie:
GSK-3
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten